Cell Surface Markers Market Size 2021, Growth Drivers, Challenges, Trends And Market Dynamics Forecast 2027
Protein or antigenic determinants located on the surface of various types of cells are known as cell surface markers. They also serve as a marker for determining the cell type. Cell surface marker analysis is used to determine ligands or drug response in research activities. The progress of healthcare technology, as well as a growing desire to reduce healthcare expenditure by lowering the cost of diagnosis, are driving the expansion of this market. However, the market's expansion has been stifled by sophisticated products and expensive apparatus and reagents needed in cell marker analysis.
Flow
Cytometers, haematological analyzers, reagents, and kits make up the global
cell surface marker market. Flow Cytometers and haematological analyzers are
the most common pieces of equipment utilised in cell marker analysis. Due to
the large variety of flow cytometers available, the flow cytometer is the most
extensively used tool. Flow cytometers have proven to be useful in both drug
discovery and research.
The global
cell surface marker market is divided into illness diagnosis, research, and
drug discovery segments. Because cell marker analysis is widely utilised by
pharmaceutical manufacturers and researchers in their research and development
process as well as in drug discovery, cell surface marker application in
research and drug discovery is projected to dominate the market.
The market
is divided into four regions: North America, Europe, Asia-Pacific, and Latin
America and the Caribbean. Because of the substantial number of research and
development efforts in this region, as well as the well-developed healthcare
infrastructure, North America dominates the cell surface marker market. Due to the rising need for targeted medicines that are both safe and effective,
Asia-Pacific and LAMEA are the fastest expanding markets.
Some of the
major competitors in this industry include Bio-Rad, Abbott Laboratories,
Seimens Healthcare, Beckman Coulter, Roche Diagnostics, BD Biosciences, and
Nihon Kohden Corporation. These companies' competitive strategies include
partnerships, product launches, mergers and acquisitions, and research and
development.

Comments
Post a Comment